ramosetron has been researched along with hydroxyindoleacetic acid in 1 studies
| Studies (ramosetron) | Trials (ramosetron) | Recent Studies (post-2010) (ramosetron) | Studies (hydroxyindoleacetic acid) | Trials (hydroxyindoleacetic acid) | Recent Studies (post-2010) (hydroxyindoleacetic acid) |
|---|---|---|---|---|---|
| 194 | 94 | 83 | 8,911 | 322 | 594 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chikumi, H; Hitsuda, Y; Kawasaki, Y; Kometani, Y; Matsumoto, S; Matsumoto, Y; Mikami, M; Nakamoto, M; Sasaki, T; Tokuyasu, H | 1 |
1 other study(ies) available for ramosetron and hydroxyindoleacetic acid
| Article | Year |
|---|---|
[Relationship between cancer chemotherapeutic drug-induced delayed emesis and plasma levels of substance P in two patients with small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Small Cell; Cisplatin; Humans; Hydroxyindoleacetic Acid; Lung Neoplasms; Male; Serotonin; Serotonin Antagonists; Substance P; Vomiting, Anticipatory | 1999 |